Insulet
PODD
#1018
Rank
A$30.32 B
Marketcap
$431.83
Share price
-0.50%
Change (1 day)
70.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.52 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.07 Billion. , an increase over its 2023 earnings that were of A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 A$0.54 B36.72%
2023 A$0.39 B481.9%
2022 A$68.25 M-45.24%
2021 A$0.12 B43.35%
2020 A$86.94 M18.51%
2019 A$73.36 M41.16%
2018 A$51.97 M-711.95%
2017 -A$8.5 Million-56.85%
2016 -A$19.69 Million-79.31%
2015 -A$95.17 Million63.85%
2014 -A$58.08 Million31.04%
2013 -A$44.33 Million-21.96%
2012 -A$56.8 Million
2010 -A$54.17 Million-42.38%
2009 -A$94.01 Million-33.56%
2008 -A$0.15 Billion65.93%
2007 -A$85.28 Million209.75%
2006 -A$27.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$64.18 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.15 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.15 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.62 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.10 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.46 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$20.08 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA